In superbug war, reliance on just a few drugmakers fuels concern

A dependence on only a few pharma companies to sustain the fight against superbugs is putting the world in a precarious position, a new report shows.

Progress in tackling drug-resistant infections isn't keeping pace with the rising threat, according to the latest Antimicrobial Resistance Benchmark, published Tuesday by the Access to Medicine Foundation.…